Latest Insider Transactions at Denali Therapeutics Inc. (DNLI)
This section provides a real-time view of insider transactions for Denali Therapeutics Inc. (DNLI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Denali Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Denali Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2022
|
Douglas G. Cole Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,986
+21.13%
|
-
|
|
Jun 02
2022
|
Marc Tessier Lavigne Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,986
+0.29%
|
-
|
|
Jun 02
2022
|
Peter S Klein Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,986
+34.6%
|
-
|
|
Jun 02
2022
|
David P Schenkein Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,986
+34.6%
|
-
|
|
Mar 23
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
20,000
-0.49%
|
$660,000
$33.77 P/Share
|
|
Feb 11
2022
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,918
-1.68%
|
$99,212
$34.71 P/Share
|
|
Feb 11
2022
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
2,803
-0.6%
|
$95,302
$34.68 P/Share
|
|
Feb 11
2022
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
2,560
-2.09%
|
$87,040
$34.69 P/Share
|
|
Feb 11
2022
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
9,491
-0.44%
|
$322,694
$34.72 P/Share
|
|
Feb 10
2022
|
Ryan J. Watts President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
70,749
+11.27%
|
$495,243
$7.44 P/Share
|
|
Feb 09
2022
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
1,423
-0.85%
|
$52,651
$37.1 P/Share
|
|
Feb 09
2022
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
1,423
-0.31%
|
$52,651
$37.1 P/Share
|
|
Feb 09
2022
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
2,719
-0.13%
|
$100,603
$37.55 P/Share
|
|
Feb 09
2022
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
1,296
-1.04%
|
$47,952
$37.09 P/Share
|
|
Feb 03
2022
|
Erik Harris Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,869
+50.0%
|
-
|
|
Jan 08
2022
|
Nancy Thornberry Director |
BUY
Grant, award, or other acquisition
|
Direct |
627
+19.98%
|
-
|
|
Jan 05
2022
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
2,846
-0.62%
|
$125,224
$44.77 P/Share
|
|
Jan 05
2022
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,845
-1.71%
|
$125,180
$44.78 P/Share
|
|
Jan 05
2022
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
2,225
-1.76%
|
$97,900
$44.75 P/Share
|
|
Jan 05
2022
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
5,007
-0.24%
|
$220,308
$44.78 P/Share
|
|
Jan 03
2022
|
Steve E. Krognes Director |
BUY
Grant, award, or other acquisition
|
Direct |
31,000
+19.71%
|
-
|
|
Jan 03
2022
|
Ryan J. Watts President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
62,000
+22.49%
|
-
|
|
Jan 03
2022
|
Carole Ho Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,000
+22.41%
|
-
|
|
Jan 03
2022
|
Alexander O. Schuth COFO and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
31,000
+20.88%
|
-
|
|
Dec 30
2021
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Indirect |
20,047
-3.95%
|
$902,115
$45.46 P/Share
|
|
Dec 29
2021
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Indirect |
32,104
-11.11%
|
$1,380,472
$43.88 P/Share
|
|
Dec 28
2021
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Indirect |
10,980
-3.66%
|
$483,120
$44.37 P/Share
|
|
Dec 06
2021
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,476
-1.9%
|
$61,992
$42.52 P/Share
|
|
Dec 06
2021
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
10,000
-1.08%
|
$420,000
$42.14 P/Share
|
|
Dec 01
2021
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
18,333
-0.29%
|
$824,985
$45.35 P/Share
|
|
Nov 10
2021
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-0.65%
|
$86,632
$52.9 P/Share
|
|
Nov 04
2021
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
10,000
-1.06%
|
$520,000
$52.94 P/Share
|
|
Nov 01
2021
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-1.29%
|
$83,300
$50.05 P/Share
|
|
Nov 01
2021
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
18,333
-0.43%
|
$898,317
$49.24 P/Share
|
|
Oct 04
2021
|
Marc Tessier Lavigne Director |
BUY
Bona fide gift
|
Indirect |
300,000
+50.0%
|
-
|
|
Oct 04
2021
|
Marc Tessier Lavigne Director |
SELL
Bona fide gift
|
Direct |
300,000
-11.79%
|
-
|
|
Oct 04
2021
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
10,000
-1.04%
|
$500,000
$50.64 P/Share
|
|
Oct 01
2021
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
18,333
-0.28%
|
$916,650
$50.27 P/Share
|
|
Sep 20
2021
|
Alexander O. Schuth COFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
9,045
+8.65%
|
$0
$0.68 P/Share
|
|
Sep 15
2021
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-0.32%
|
$88,298
$53.5 P/Share
|
|
Sep 07
2021
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
10,000
-0.69%
|
$550,000
$55.47 P/Share
|
|
Sep 01
2021
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
18,333
-0.42%
|
$989,982
$54.59 P/Share
|
|
Aug 23
2021
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
6,143
-3.73%
|
$294,864
$48.91 P/Share
|
|
Aug 19
2021
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
2,285
-1.17%
|
$111,965
$49.8 P/Share
|
|
Aug 19
2021
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
2,376
-0.05%
|
$116,424
$49.68 P/Share
|
|
Aug 19
2021
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
2,544
-0.26%
|
$124,656
$49.83 P/Share
|
|
Aug 19
2021
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
2,546
-0.76%
|
$124,754
$49.61 P/Share
|
|
Aug 18
2021
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-0.63%
|
$84,966
$51.69 P/Share
|
|
Aug 04
2021
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
10,000
-0.68%
|
$520,000
$52.28 P/Share
|
|
Aug 02
2021
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
18,333
-0.42%
|
$934,983
$51.37 P/Share
|